Your browser doesn't support javascript.
loading
CYP2D6 Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer Patients.
Ahmed, Jemal Hussien; Makonnen, Eyasu; Fotoohi, Alan; Aseffa, Abraham; Howe, Rawleigh; Aklillu, Eleni.
Afiliação
  • Ahmed JH; Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, Addis Ababa P.O. Box 9086, Ethiopia. jemal.hussien@ju.edu.et.
  • Makonnen E; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm 141 86, Sweden. jemal.hussien@ju.edu.et.
  • Fotoohi A; Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, Addis Ababa P.O. Box 9086, Ethiopia. eyasumakonnen@yahoo.com.
  • Aseffa A; Center for Innovative Drug Development and Therapeutic Trials, Addis Ababa University, Addis Ababa P.O. Box 9086, Ethiopia. eyasumakonnen@yahoo.com.
  • Howe R; Division of Clinical Pharmacology, Department of Medicine, Karolinska Institutet, Solna Stockholm 171 76, Sweden. Alan.Fotoohi@ki.se.
  • Aklillu E; Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia. aseffaa@gmail.com.
Cancers (Basel) ; 11(9)2019 Sep 12.
Article em En | MEDLINE | ID: mdl-31547390

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2019 Tipo de documento: Article